Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs

About this update from Harbin Pharmaceutical Group Co., Ltd. Class A

Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Harbin Pharmaceutical Group Co., Ltd. Class A